Přehled studií citovaných v článcích tohoto čísla Kardiologické revue

Vyšlo v časopise: Kardiol Rev Int Med 2006, 8(3): 147

  • ASCOT-LLA – Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm
  • ASPEN – Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent Diabetes Mellitus
  • BARI II – Bypass Angioplasty Revascularization Investigation II
  • BETACAR – Betaxolol versus Carvedilol in Chronic Heart Failure
  • BIPS – Bezafibrat Infarction Prevention Study
  • CAPRICORN – Carvedilol Post Infarct Survival Control in LVD
  • CAPRIE – Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE) study
  • CARDS – Collaborative Atorvastatin Diabetes Study
  • CARE – Cholesterol And Recurrent Events
  • CIBIS II – The Second Cardiac Insufficiency Bisoprolol Study
  • CLARITY – Cladribine Tablets in Treating MS Orally Study
  • COMET – Carvedilol or Metoprolol European Trial Study
  • COMMIT/CCS-2 – Clopidogrel and Metoprolol in Myocardial Infarction Trial Study
  • COPERNICUS – Carvedilol Prospective Randomized Cumulative Survival
  • CREDO – The Clopidogrel for the Reduction of Events During Observation Study
  • CURE – The Clopidogrel in Unstable Angina to Prevent Recurrent Events
  • DAIS – Diabetes Atherosclerosis Intervention Study
  • DCCT – Diabetes Control and Complications Trial Study
  • DIGAMI – Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction
  • DIGAMI II – Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction 2
  • EDIC – Epidemiology of Diabetes Interventions and Complications Study
  • ETDRS – Early Treatment Diabetic Retinopathy Study
  • EUROPA – European Trial on Reduction of Cardiac Events with Perindopril in Stable Artery Coronary Disease
  • FIELD – Fenofibrate Intervention and Event Lowering in Diabetes
  • GREACE – Greek Atorvastatin and Coronary-heart-disease Evaluation
  • HOPE – Heart Outcomes Prevention Study
  • HPS – Heart Protection Study
  • CHARISMA – Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance
  • ISAR – Diabetes Study Paclitaxel-eluting and Sirolimus-eluting stents to Prevent Restenosis in Diabetic Patients
  • ISIS-1 – Second International Study of Infarct Survival
  • LATE-BASKET – Late Clinical Events Related to Late Stent Thrombosis After Stopping Clopidogrel: Drug-Eluting vs Bare-Metal Stenting
  • LIPID – Long-term Intervention with Pravastatin in Ischemic Disease
  • MADIT II – Multicenter Automatic Defibrillator Implantation Trial II
  • MERIT HF – The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure Study
  • MIAMI – Metoprolol in Acute Myocardial Infarction Study
  • MIRACLE – Multicenter InSync Randomized Clinical Evaluation
  • ONTARGET – Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Study
  • PEACE – Prevention of Events with Angiotensin-Converting Enzyme Inhibition
  • PHS – Physicians’ Health Study
  • POPADAD – The Prevention of Progression of Asymptomatic Diabetic Arterial Disease Study
  • PPP – Primary Prevention Project
  • PROACTIVE – Prospective Pioglitazone Clinical Trial in Macro Vascular Events
  • SCORE – The Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study
  • SENIORS – Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure
  • SIRIUS – SirolimUS-Eluting Stent in De Novo Native Coronary Lesions
  • STOP NIDDM – Study to Prevent Non-Insulin-Dependent Diabetes Mellitus
  • TIMI-2B – Thrombolysis in Myocardial Infarction 2B Study
  • TNT – The Treating to New Targets
  • UKPDS – United Kingdom Prospective Diabetes Study
  • 4S – Scandinavian Simvastatin Survival Study.

Dětská kardiologie Interní lékařství Kardiochirurgie Kardiologie
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se